Literature DB >> 10092217

Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic.

S Arab1, C A Lingwood.   

Abstract

The pentameric B subunit of verotoxin (VT) mediates the attachment to cell surface globotriaosyl ceramide (Gb3) to facilitate receptor-mediated endocytosis of the toxin. In highly toxin-sensitive tumor cells, the holotoxin and VT1 B subunit is targeted intracellularly to elements of the endoplasmic reticulum (ER)/nuclear membrane. In less sensitive cells, the toxin is targeted to components of the Golgi apparatus. We have studied two cell systems: the induced VT hypersensitivity of human astrocytoma cell lines cultured in the presence of sodium butyrate (compared to sodium propionate and capronate) and the increased VT sensitivity of multiple drug-resistant mutants as compared to parental human ovarian carcinoma cells. In both cases, a difference in the intracellular retrograde transport of the receptor-bound internalized toxin to the ER/nuclear envelope, as opposed to the Golgi, correlated with a >1,000-fold increase in cell sensitivity to VT. This change in intracellular routing may be due to sorting of Gb3 fatty acid isoforms, since nuclear targeting was found in turn to correlate with the preferential synthesis of Gb3 containing shorter chain (primarily C16) fatty acid species. We propose that the isoform-dependent traffic of Gb3 from the cell surface to the ER/nuclear membrane provides a new signal transduction pathway for Gb3 binding proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10092217     DOI: 10.1002/(SICI)1097-4652(199812)177:4<646::AID-JCP15>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  31 in total

Review 1.  Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives.

Authors:  K Sandvig; B van Deurs
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

2.  Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.

Authors:  T Falguières; F Mallard; C Baron; D Hanau; C Lingwood; B Goud; J Salamero; L Johannes
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

Review 3.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

4.  Study on induction of apoptosis on HeLa and Vero cells by recombinant shiga toxin and its subunits.

Authors:  Saeid Bouzari; Mana Oloomi; Kayhan Azadmanesh
Journal:  Cytotechnology       Date:  2009-08-09       Impact factor: 2.058

5.  An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.

Authors:  Miho Watanabe-Takahashi; Toshio Sato; Taeko Dohi; Noriko Noguchi; Fumi Kano; Masayuki Murata; Takashi Hamabata; Yasuhiro Natori; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

6.  Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells.

Authors:  S Arab; M Murakami; P Dirks; B Boyd; S L Hubbard; C A Lingwood; J T Rutka
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

Review 7.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

8.  Shigatoxin-1 binding and receptor expression in human kidneys do not change with age.

Authors:  Zuhal Ergonul; Frederic Clayton; Agnes B Fogo; Donald E Kohan
Journal:  Pediatr Nephrol       Date:  2003-02-07       Impact factor: 3.714

9.  Interaction of the verotoxin 1B subunit with soluble aminodeoxy analogues of globotriaosyl ceramides.

Authors:  Murugesapillai Mylvaganam; Henrik C Hansen; Beth Binnington; Göran Magnusson; Per-Georg Nyholm; Clifford A Lingwood
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

10.  The ether lipid precursor hexadecylglycerol protects against Shiga toxins.

Authors:  Jonas Bergan; Tore Skotland; Anne Berit Dyve Lingelem; Roger Simm; Bjørn Spilsberg; Toril Lindbäck; Tuulia Sylvänne; Helena Simolin; Kim Ekroos; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2014-04-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.